Zilver PTX Post-Market Surveillance Study of Paclitaxel-Eluting Stents for Treating Femoropopliteal Artery Disease in Japan
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 05 Jul 2017
At a glance
- Drugs Paclitaxel (Primary)
- Indications Peripheral arterial disorders
- Focus Adverse reactions; Therapeutic Use
- Sponsors Cook Medical
- 20 Oct 2016 Planned End Date changed from 1 May 2017 to 1 Feb 2018.
- 20 Oct 2016 Planned primary completion date changed from 1 May 2017 to 1 Feb 2018.
- 09 Oct 2014 New trial record